MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology

NEW YORK , Aug. 3, MindMed (NASDAQ: MNMD ) (NEO: MMED) (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, announced today that it will participate in and financially support the Digital Medicine Society’s (DiMe) Digital Health Measurement Collaborative Community (DATAcc), an effort to develop best practices and streamline the medical field’s approaches to measuring health using digital technologies.

Read the source article at PR Newswire
2021-08-03 15:30:00